Meta Information
ID:myo-inositol-d-chiro-inositol
Name:Myo-Inositol and D-Chiro-Inositol
Schema Version:1.5
Alternate Names
- MI/DCI
- Inositol combination
Active Compound
myo-inositol; d-chiro-inositol
Intervention Type
synergistic_therapy
Delivery
Route:
oral
Scope:
- systemic
Regulatory Status
- us:dietary_supplement
- eu:food_supplement
Indication
Focus:
healthspan
Description:
Supporting metabolic health, insulin sensitivity, and cellular glucose utilization.
Typical Protocol
- Common protocols for metabolic support involve daily oral intake, often in a 40:1 myo-inositol to d-chiro-inositol ratio, typically totaling 2-4 grams per day.
Expected Cost Mean
Low Cost:
20
High Cost:
50
Cost Type:
monthly
Description:
Monthly cost for a typical supplemental dose; generally not insurance-covered.
Summary
Myo-inositol and d-chiro-inositol are intracellular second messengers crucial for proper insulin signaling and glucose utilization within cells. Their combined supplementation aims to enhance insulin sensitivity, improve cellular energy metabolism, and mitigate metabolic dysregulation, thereby contributing to metabolic resilience and supporting a longer healthspan.
Purpose
Supports metabolic health, insulin signaling, and cellular function for healthy aging.
Card Summary
Enhances insulin sensitivity and glucose metabolism, vital for long-term metabolic health and resilience.
Drug Class
null
Drugs In Class
Empty Array
Impact
Score:
5.5
Justification:
Modulates insulin signaling, supports metabolic resilience and glucose control.
Evidence
Grade:
B
Score:
7
Justification:
Robust human trials for metabolic conditions; indirect for broad healthspan.
Safety
Score:
3
Justification:
Generally well-tolerated; mild gastrointestinal upset possible at high doses.
Flags
- High doses may cause mild gastrointestinal distress such as nausea or diarrhea.
- Specific myo-inositol to d-chiro-inositol ratios (e.g., 40:1) are often studied for particular indications, such as PCOS.
Verdict
Aids metabolic health; generally safe; supports insulin signaling.